Document is current
Any future updates will be listed below
-
Authors
Makhov, Peter https://orcid.org/0000-0002-8257-4782
Sohn, Ji A.
Serebriiskii, Ilya G.
Fazliyeva, Rushaniya
Khazak, Vladimir
Boumber, Yanis
Uzzo, Robert G.
Kolenko, Vladimir M.
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Cancer Institute (CA216173, CA246011, CA223394, CA223394, CA212949, CA235060)
U.S. Department of Health & Human Services | NIH | National Cancer Institute
U.S. Department of Health & Human Services | NIH | National Cancer Institute
U.S. Department of Health & Human Services | NIH | National Cancer Institute
U.S. Department of Health & Human Services | NIH | National Cancer Institute
U.S. Department of Defense (KC170127)
U.S. Department of Health & Human Services | NIH | National Cancer Institute
- License Information
-
More Information
Article History
Received: 18 November 2019
Revised: 17 August 2020
Accepted: 3 September 2020
First Online: 24 September 2020
Ethics approval and consent to participate
: All animal studies were performed under approval from the Fox Chase Cancer Center Institutional Animal Care and Use Committee and followed Fox Chase Cancer Center and NIH guidelines. 786-O cell line was obtained from ATCC. PNX0010 cell line was a gift from Dr. Vladimir Khazak (Priaxon Inc.)
: All data are available via the corresponding author.
: The authors declare no competing interests.
: This work was supported in part by the National Institutes of Health Grants R03 CA216173 and R03 CA246011 (to P.M.); R21 CA223394 (to Y.B. and P.M.); R03 CA212949 and R03 CA235060 (to V.M.K.), the Department of Defense Idea Development Award KC170127 (to V.M.K.), and the NCI Core Grant NCI P30 CA006927 (to Fox Chase Cancer Center).
